Use of an Alfa-lipoic, Methylsulfonylmethane, Boswellia Serrata and Bromelain Dietary Supplement (OPERA®) for Aromatase Inhibitors-related Arthralgia Management (AIA): a prospective phase II trial (NCT04161833)
Research Square (Research Square)